U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Links from BioSample

DRX048718: Illumina HiSeq 2500 sequencing of SAMD00044263
1 ILLUMINA (Illumina HiSeq 2500) run: 29.5M spots, 1.1G bases, 684.5Mb downloads

Submitted by: RIKEN_IMS
Study: Time-course mRNA expression analysis of human breast cancer MCF-7 cells treated with tamoxifen up to 12 weeks
show Abstracthide Abstract
In current study, we performed 12-weeks time-course mRNA expression analysis on the biological sextuplicate samples of estrogen receptor (ER)-positive MCF-7 breast cancer cells in presence or absence of tamoxifen to capture cellular state changes associated with acquisition of tamoxifen resistance. mRNA (1 mg) obtained from the MCF-7 cells was used for Poly A+ mRNA-sequence using the Illumina TruSeq RNA Library Prep Kit v2 according to the manufacturer protocol. 100 base pair-end reads or 36 base single-end-reads were obtained using Hiseq2500 (Illumina) and analyzed by analysis software provided by Illumina. To ensure the validity of the experiment, expression of representative genes (such as EGFR, ErbB2 (HER2), IGF-IR, NCOA3 (AIB1), MYC, CCND1 (cyclin D1) and CCNE1) known for tamoxifen resistance in vitro and clinical setting (Musgrove 2009) were confirmed.
Sample: MCF7_tamoxifen_12week_replicate1
SAMD00044263 • DRS056718 • All experiments • All runs
Organism: Homo sapiens
Library:
Instrument: Illumina HiSeq 2500
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: SINGLE
Construction protocol: Illumina TruSeq RNA Library Prep Kit v2
Spot descriptor:
forward

Runs: 1 run, 29.5M spots, 1.1G bases, 684.5Mb
Run# of Spots# of BasesSizePublished
DRR05383629,480,8291.1G684.5Mb2017-12-21

ID:
4868203

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...